Nafazatrom, an arachidonate metabolism inhibitor, decreases prolactin and GH release
- 1 September 1986
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 128 (3) , 151-156
- https://doi.org/10.1016/0014-2999(86)90761-2
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Angiotensin Peptides Stimulate Phosphoinositide Breakdown and Prolactin Release in Anterior Pituitary Cells in Culture*Endocrinology, 1986
- Maitotoxin, a Calcium Channel Activator, Increases Prolactin Release from Rat Pituitary Tumor 7315a Cells by a Mechanism That May Involve Leukotriene ProductionNeuroendocrinology, 1986
- 5-Hydroxyeicosatetraenoic Acid Increases Prolactin Release from Rat Anterior Pituitary Cells*Endocrinology, 1985
- Comparison of the effects of some compounds on human neutrophil degranulation and leukotriene B4 and thromboxane B2 synthesisBiochemical Pharmacology, 1985
- Evidence Supporting a Correlation between Arachidonic Acid Release and Prolactin Secretion from GH3Cells*Endocrinology, 1985
- The Effects of Maitotoxin on45Ca2+Flux and Hormone Release in GH3 Rat Pituitary Cells*Endocrinology, 1985
- Arachidonate Stimulates Prolactin Releasein Vitro: A Role for the Fatty Acid and Its Metabolites as Intracellular Regulator(s) in Mammotrophs*Endocrinology, 1985
- Modification of Basal and GRF-Stimulated Cyclic AMP Levels and Growth Hormone Release by Phospholipid Metabolic Enzyme InhibitorsNeuroendocrinology, 1985
- A Possible Role of Prostacyclin to Stimulate Prolactin and Growth Hormone Release by Hypothalamic and Pituitary Actions, Respectively*Endocrinology, 1984
- Nafazatrom (bay g 6575) inhibition of tumor cell lipoxygenase activity and cellular proliferationFEBS Letters, 1982